You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

The sympathetic nervous system and the metabolic syndrome

Mancia, Giuseppea; Bousquet, Pascalb; Elghozi, Jean Lucc; Esler, Murrayd; Grassi, Guidoa; Julius, Stevoe; Reid, Johnf; Van Zwieten, Peter Ag

Journal of Hypertension:
doi: 10.1097/HJH.0b013e328048d004
Reviews
Abstract

Studies performed in the past two decades have unequivocally shown that several of the components of the metabolic syndrome are associated with indirect and direct markers of adrenergic overdrive. This is the case for hypertension and obesity, in which resting tachycardia, elevated plasma norepinephrine values, increased sympathetic nerve traffic, as well as augmented levels of total and regional norepinephrine spillover have been reported. This is also the case for insulin resistance, i.e. a metabolic condition frequently complicating the various components of the pathological condition identified as the ‘metabolic syndrome’. After briefly describing the epidemiological and the cardiovascular risk profile of the disease, this paper will examine the behaviour of the sympathetic nervous system in the metabolic syndrome as well as the mechanisms potentially responsible for this neurogenic abnormality. This will be followed by an analysis of the role played by neuroadrenergic factors in disease progression as well as in the pathogenesis of its complications. Finally, the therapeutic implications of these findings will be highlighted.

Author Information

aOspedale San Gerardo dei Tintori, Università Milano-Bicocca, Monza (Milan), Italy

bULP – Faculté de Médecine, Strasbourg, France

cHôpital Necker Enfants Malades, UF de Pharmacologie Clinique, Paris, France

dBaker Medical Research Institute, Melbourne, Australia

eThe University of Michigan Health System, Department of Internal Medicine, Ann Arbor, Michigan, USA

fUniversity of Glasgow, Department of Medicine and Therapeutics, Gardiner Institute, Glasgow, Scotland

gAcademic Medical Center University of Amsterdam, Departments of Pharmacotherapy, Cardiology and Cardiopulmonary Surgery, Amsterdam, The Netherlands

Received 22 June, 2006

Revised 13 November, 2006

Accepted 14 December, 2006

Correspondence and requests for reprints to Giuseppe Mancia, Clinica Medica, Ospedale San Gerardo dei Tintori, Via Pergolesi 33, 20052 Monza (Milan), Italy Tel: +39 039 233 374; fax: +39 039 322 274; e-mail: giuseppe.mancia@unimib.it

© 2007 Lippincott Williams & Wilkins, Inc.